Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

SANTINI, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.965
AS - Asia 1.705
EU - Europa 1.430
Continente sconosciuto - Info sul continente non disponibili 279
SA - Sud America 258
AF - Africa 55
OC - Oceania 1
Totale 8.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.900
SG - Singapore 690
RU - Federazione Russa 467
CN - Cina 404
IT - Italia 289
BR - Brasile 187
HK - Hong Kong 165
DE - Germania 149
VN - Vietnam 145
PL - Polonia 106
GB - Regno Unito 84
FR - Francia 83
BD - Bangladesh 64
FI - Finlandia 61
JP - Giappone 54
IE - Irlanda 44
SE - Svezia 43
IN - India 35
CA - Canada 33
KR - Corea 29
AR - Argentina 25
UA - Ucraina 19
ES - Italia 18
TR - Turchia 18
AT - Austria 17
EC - Ecuador 17
IQ - Iraq 16
IR - Iran 14
NL - Olanda 13
MA - Marocco 12
MX - Messico 11
PK - Pakistan 11
UZ - Uzbekistan 11
EG - Egitto 10
RO - Romania 10
VE - Venezuela 10
ZA - Sudafrica 9
CI - Costa d'Avorio 8
BE - Belgio 7
CO - Colombia 7
ID - Indonesia 7
KE - Kenya 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 5
PY - Paraguay 5
CL - Cile 4
CR - Costa Rica 4
JM - Giamaica 4
LT - Lituania 4
SA - Arabia Saudita 4
TN - Tunisia 4
AL - Albania 3
BH - Bahrain 3
JO - Giordania 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
BG - Bulgaria 2
CH - Svizzera 2
ET - Etiopia 2
HN - Honduras 2
LB - Libano 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
PE - Perù 1
RS - Serbia 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 8.418
Salva come PNG Salva come JPEG
Città #
Fairfield 750
Ashburn 589
Singapore 426
Woodbridge 347
Houston 293
Seattle 288
San Jose 267
Wilmington 256
Cambridge 225
Chandler 217
Hong Kong 158
Ann Arbor 116
Moscow 98
Zgierz 89
Council Bluffs 79
Beijing 76
Los Angeles 70
Medford 67
Altamura 59
Chicago 57
Tokyo 49
Ho Chi Minh City 46
Lauterbourg 46
Helsinki 45
Dublin 44
Lawrence 42
Princeton 42
Des Moines 39
New York 39
London 38
Santa Clara 38
Palermo 37
Dallas 35
Hanoi 35
Hefei 34
Dearborn 33
Nanjing 32
San Diego 31
Boardman 27
Ludwigshafen am Rhein 27
Frankfurt am Main 26
Phoenix 26
São Paulo 24
Salt Lake City 23
Panama City 22
Rome 22
Seoul 22
Berlin 18
Buffalo 18
The Dalles 18
Milan 17
Elk Grove Village 16
Shenyang 16
Nanchang 15
Changsha 14
Denver 14
Jinan 13
Orem 13
San Paolo di Civitate 13
Atlanta 12
Chennai 12
Nuremberg 12
Brooklyn 11
Da Nang 11
Hebei 11
Izmir 11
Montreal 11
Warsaw 11
Guangzhou 10
Tampa 10
Tianjin 10
Toronto 10
Cairo 9
Tehran 9
Abidjan 8
Schiffdorf 8
Shanghai 8
Tulsa 8
Amsterdam 7
Brussels 7
Hangzhou 7
Mexico City 7
Redwood City 7
Tashkent 7
Baghdad 6
Boydton 6
Guayaquil 6
Haiphong 6
Jiaxing 6
Nairobi 6
Springfield 6
Vienna 6
Biên Hòa 5
Detroit 5
Düsseldorf 5
Falkenstein 5
Johannesburg 5
Lappeenranta 5
Lucera 5
Miami 5
Totale 5.958
Salva come PNG Salva come JPEG
Nome #
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 349
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 329
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 285
Update on capecitabine alone and in combination regimens in colorectal cancer patients 279
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. 277
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 264
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 259
Lack of Correlation between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: A Retrospective Study 246
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 232
Cetuximab in small bowel adenocarcinoma: A new friend 231
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 230
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis 229
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 226
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 224
New molecular targets in bone metastases 219
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 218
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 218
Deregulation of dicer and mir-155 expression in liposarcoma 215
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis 209
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules 200
Hepatocellular carcinoma treatment over sorafenib: Epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? 197
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 193
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter 192
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 185
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 177
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas 167
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: A new pharmacodynamic marker? 164
Pharmacogenomics of cetuximab in metastatic colorectal carcinoma 160
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential 159
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 155
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary 155
The dark side of the moon: The PI3K/PTEN/AKT pathway in colorectal carcinoma 153
Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment † 153
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 148
Recent advances in desmoid tumor therapy 146
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] 146
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 144
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies 133
The use of same in chemotherapy-induced liver injury 132
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors 118
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 117
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 112
S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens 108
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 89
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 88
Small bowel carcinomas in celiac or Crohn's disease: Distinctive histophenotypic, molecular and histogenetic patterns 60
null 3
Totale 8.693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.196
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022523 0 123 25 13 8 17 25 38 45 69 79 81
2022/2023691 64 173 14 51 62 96 29 64 77 6 37 18
2023/2024270 20 30 32 15 17 33 35 9 2 4 3 70
2024/20251.044 14 85 46 47 23 56 63 103 57 114 240 196
2025/20262.981 274 104 179 223 360 381 410 339 269 166 137 139
2026/2027200 181 19 0 0 0 0 0 0 0 0 0 0
Totale 8.693